logo
NHS scheme to prevent brain injuries in childbirth extended across England

NHS scheme to prevent brain injuries in childbirth extended across England

Business Mayor12-05-2025

An NHS programme to boost maternity safety and prevent brain injuries during childbirth is to be rolled out across England.
The avoiding brain injuries in childbirth (ABC) programme is designed to help maternity staff better identify signs that a baby is in distress during labour so they can act quickly.
It is also intended to help staff respond more effectively to obstetric emergencies, such as where the baby's head becomes lodged deep in the mother's pelvis during a caesarean birth.
The government said the programme, which will begin from September and follows a pilot scheme in nine maternity units, would reduce the number of avoidable brain injuries during childbirth, helping to prevent lifelong conditions such as cerebral palsy.
The health secretary, Wes Streeting, said: 'All expectant mothers giving birth in an NHS hospital should have peace of mind that they are in safe hands. This vital programme will give staff across the country the right tools and training to deliver better care to women and their babies, reducing the devastating impact of avoidable brain injuries.'
The most recent data from the neonatal data analysis unit at Imperial College London shows that 2,490 babies had at least one episode of care for brain injury during or after birth in 2021, equating to 4.2 per 1,000 live births.
The pilot scheme, which launched in October, was delivered by the Royal College of Obstetricians and Gynaecologists (RCOG), the Royal College of Midwives (RCM) and the Healthcare Improvement Studies Institute (This).
Ranee Thakar, the RCOG president, said: 'The ABC programme supports multidisciplinary maternity teams to deliver safer, more personalised care. Hundreds of maternity staff, including obstetricians, midwives and anaesthesiologists, have been involved in developing and testing this quality improvement programme.
'We have heard what a difference it makes, supporting teams to work effectively together in time-sensitive and high-pressure situations. The RCOG is extremely proud to have been part of this fantastic collaboration.'
The government said the programme should give clinicians more confidence to take swift action managing an emergency.
The RCM chief executive, Gill Walton, said: 'The ABC programme has brought together all those involved in maternity care, offering practical solutions to some of the most acute clinical challenges.
'Crucially the ABC programme tools and training have been developed based on the voices of women, families and maternity staff. This has been the key to the success of the pilot programme. Equally, the will and drive of midwives and the wider multidisciplinary team to improve safety and outcomes for women and their families has been evident across the course of the training at the pilot sites.'
The programme is expected to reduce inequalities in maternity outcomes across England so that most maternity units achieve outcomes comparable to the current highest-performing 20% of trusts.
Prof Mary Dixon-Woods, the director of This, said the programme would reduce unwarranted variation. 'The pilot has shown that it's possible to train people effectively and efficiently,' she said. 'A national commitment to implement the programme at scale will be important in ensuring that the benefits are seen.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

ADHD drugs back in the spotlight after study debunks rising prevalence
ADHD drugs back in the spotlight after study debunks rising prevalence

Yahoo

time2 hours ago

  • Yahoo

ADHD drugs back in the spotlight after study debunks rising prevalence

An increasing number of patients are seeking support for attention-deficit/hyperactivity disorder (ADHD), with pharmacological-based treatments an important part of medical care for the neurodevelopmental condition. A study published this week in the Journal of Affective Disorders has found that greater awareness and acceptance around the disorder has led to more people seeking help. The research, led by a team at King's College, London, debunks claims that the disorder is 'naturally' on the rise. The data comes as a national taskforce in England investigates what this rising demand for support means for the NHS. Figures published in May 2025 by NHS England estimated there were nearly 2.5 million people in England with ADHD. This includes more than 550,000 currently waiting for an assessment. Every month 20,000 more people are referred for support, a rise of 13% compared to last year. Pharmaceutical Technology looks at some of the current options in the UK and casts an eye ahead to what the future drug landscape might contain. The first choice for patients with ADHD is methylphenidate, which belongs to a class of drugs called central nervous system (CNS) stimulants. The drug, which works by blocking the reuptake of norepinephrine and dopamine, increases activity in the brain, including regions associated with attention and behaviour. It is known under the brand names Ritalin, manufactured by Novartis, and Johnson and Johnson's Concerta. There is also Equasym and Xenidate, among others. Lisdexamfetamine dimesylate is also used to treat patients with ADHD. Like methylphenidate, lisdexamfetamine is a CNS stimulant and acts as a norepinephrine and dopamine reuptake inhibitor (NDRI). This drug is known under the brand name, among others, as Elvanse and Vyvanse, both manufactured by Takeda. While stimulants are fast acting, with side effects felt soon after administration, non-stimulant drugs take longer, yet can offer an alternative if drugs like methylphenidate and lisdexamfetamine dimesylate do not work. While improving, access to pharmacological-based treatments is still impaired amid an ongoing global shortage that began in September 2023. Methylphenidate and lisdexamfetamine were primarily affected – the shortage arising due to a combination of manufacturing issues and increased global demand. A separate study published in The American Journal of Managed Care in March suggested that overdiagnosis of ADHD is fuelling the shortage of stimulation medications. One of the most advanced candidate drugs, and one with notable buzz surrounding it, is Axsome's Sunosi (solriamfetol). Sunosi, which is also an NDRI but not a conventional stimulant, met its primary endpoint in a Phase III trial (NCT05972044) earlier this year. The medication led to a 45% drop in ADHD symptoms. As measured by the Adult ADHD Investigator Symptom Rating Scale (AISRS), 150mg Sunosi dosed achieved average reductions from baseline of 17.7 points, compared to 14.3 points for placebo. Sunosi is already approved in the UK to treat excessive daytime sleepiness (EDS) in adults with narcolepsy, with or without cataplexy. Certain patients with obstructive sleep apnoea (OSA) are also eligible to take the medication. In 2022, Axsome paid $53m up front to acquire Sunosi from Jazz Pharmaceuticals. A drug with a recent approval extension in the US, though not the UK, was Supernus Pharmaceuticals' Qelbree (viloxazine extended-release capsules). The mechanism of action of Qelbree, though unclear, is thought to be through inhibiting the reuptake of norepinephrine. Originally approved for children in 2021, the FDA updated the drug's label in January this year to include adults. ADHD treatments were in the political crosshairs in the US recently. The disorder, along with autism, was singled out by the Trump administration for an 'over-utilisation of medication'. Pharmaceutical intervention remains a helpful part of managing the disorder, though it is part of a combination of treatments that also include coaching and lifestyle changes. "ADHD drugs back in the spotlight after study debunks rising prevalence" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Hospitals to get £2.6m for infrastructure upgrades
Hospitals to get £2.6m for infrastructure upgrades

Yahoo

time5 hours ago

  • Yahoo

Hospitals to get £2.6m for infrastructure upgrades

Several hospitals are set to get upgrades after Nottinghamshire Healthcare NHS Foundation Trust has secured government funding. Work will include improving fire safety systems, water infrastructure and electrical and energy systems at Rampton Hospital, The Wells Road Centre, Wathwood Hospital, Thorneywood Mount and Arnold Lodge Hospital. The improvements at the sites, which offer mental health and community services across the Midlands and South Yorkshire, are due to start in the summer with the aim of completing next spring. Nottinghamshire Healthcare NHS Foundation Trust, which runs the hospitals, said the funding would support urgent projects and create a better environment for patients. The £2,595,000 grant is part of a national project to improve NHS buildings and infrastructure in England. At Rampton High Secure Hospital and several others, it is hoped the money will allow a full upgrade of fire safety systems - including alarms, fire compartmentation and suppression technology. The Wells Road Centre in Mapperley, Nottingham, will benefit from the replacement of ageing machinery. While at Arnold Lodge, in Leicester, a specialist secure unit, the money will deliver electrical and energy system improvements. The trust said planning work was under way to ensure the disruption was minimal. Chief executive at the trust Ifti Majid said the funding was "fantastic news", adding: "It allows us to fast-track improvements that make our hospitals safer, greener and more welcoming places to receive care and to work." Alison Wyld, executive director of finance and estates, added: "By tackling our highest-risk infrastructure now, we're not only reducing future maintenance costs but also supporting the trust's net zero ambitions." Follow BBC Nottingham on Facebook, on X, or on Instagram. Send your story ideas to eastmidsnews@ or via WhatsApp on 0808 100 2210. High-security hospital 'still needs to improve' Work begins on £12m endoscopy unit at city hospital Construction under way on new hospital theatre suite Photos show 'crumbling', abandoned hospital rooms Nottinghamshire Healthcare NHS Foundation Trust

New boss confirmed for NHS healthcare trust
New boss confirmed for NHS healthcare trust

Yahoo

time5 hours ago

  • Yahoo

New boss confirmed for NHS healthcare trust

A new chief executive has been announced at a health trust where the current boss is stepping down after more than 37 years in the NHS. Surrey and Sussex Healthcare NHS Trust (SASH) said Andrew Hines would take over in the autumn. He currently works at Barts Health NHS Trust in London as executive director for group development. Angela Stevenson, who started her career as a student nurse in Glasgow in 1988, retires in August. Trust chairperson Anita Donley said she was pleased to be announcing Mr Hines as the next chief executive. "I know he will bring energy, commitment and dedication to this role, and his experience will be instrumental in leading the trust forward into the next stage of its journey as an acute provider," she added. Mr Hines said he was delighted and proud to be taking up the role. He added: "The trust provides vital services to a growing population across east Surrey and west Sussex. "I'm looking forward to working with its fantastic staff and building on relationships with partner organisations." The trust was formed in 1998, as a result of a merger between the East Surrey Healthcare NHS Trust and Crawley Horsham NHS Trust. It runs Crawley, Horsham, Caterham Dene and East Surrey hospitals. Follow BBC Surrey on Facebook, on X, and on Instagram. Send your story ideas to southeasttoday@ or WhatsApp us on 08081 002250. Hospital chief retiring after 37 years in NHS Thousands to benefit from new NHS hub Frailty unit cuts down hospital stays for elderly Surrey and Sussex NHS Trust

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store